Life WhispererLife WhispererLife WhispererLife Whisperer
  • Home
  • Products
    • Life Whisperer Genetics
    • Life Whisperer Viability
    • Life Whisperer Genetics
    • Life Whisperer Oocytes
    • Life Whisperer Endometrial Receptivity
  • Distribution
  • News & Science
    • Press
    • IVF-X
    • Publications
  • About
  • Request a Trial
  • Home
  • Products
    • Life Whisperer Embryo Quality
    • Life Whisperer Viability
    • Life Whisperer Genetics
    • Life Whisperer Oocytes
    • Life Whisperer Endometrial Receptivity
  • Distribution
  • News & Science
    • Press
    • IVF-X
    • Publications
  • About
  • Request a Trial
  • Home
  • Products
    • Life Whisperer Genetics
    • Life Whisperer Viability
    • Life Whisperer Genetics
    • Life Whisperer Oocytes
    • Life Whisperer Endometrial Receptivity
  • Distribution
  • News & Science
    • Press
    • IVF-X
    • Publications
  • About
  • Request a Trial

Independent multicenter analysis of AI reports objective and faster embryo assessment with Life Whisperer, saving IVF clinics time and cost.

IVF Spain (subsidiary of IVF Life) and their three clinics located in Alicante, San Sebastian and Madrid, presented their recent independent study on the use of Life Whisperer Viability AI technology to evaluate embryos at the European Society of Human Reproduction and Embryology (ESHRE) 2021 Scientific Congress, June 2021.

Life Whisperer Viability uses AI to assess images of embryos to predict their likelihood of leading to a pregnancy, with the aim of improving pregnancy outcomes for IVF patients. In the study, 513 embryo images were provided by three different clinics using the EmbryoScope time-lapse imaging system. Images were evaluated using three different methods to predict pregnancy outcome: manual visual assessment using conventional Gardner grading, the time-lapse imaging AI algorithm Eeva (EV), and the Life Whisperer Viability AI software.

Results showed that Life Whisperer Viability overall was comparable to other methods for embryo selection, but had a superior sensitivity for predicting positive pregnancy outcomes. This study demonstrated generalizability of Life Whisperer Viability to a European demographic, and comparable performance without the need for manual grading or annotation. Therefore Life Whisperer Viability provides a faster, objective method for embryo assessment, ultimately saving IVF clinics time and cost.

Additionally, one of the key advantages of the Life Whisperer Viability software is that it does not require any specific hardware. Life Whisperer Viability has been shown to be camera agnostic and operates with a variety of existing camera systems already used within IVF clinics, including standard microscope-mounted cameras and more advanced time-lapse systems. The implementation of time-lapse methods requires substantial investment in specialized incubator systems, which is not possible for all clinics. Life Whisperer Viability is therefore more scalable, accessible, affordable, and equitable, for IVF clinics and their patients globally.

The poster presentation can be downloaded here.

Life Whisperer

Life Whisperer is a world-leader in the application of AI in IVF. The Life Whisperer AI embryo Viability and Genetics assessment tools are the first to be commercialized in a series of applications that encompass the complete IVF journey. Life Whisperer aims to improve IVF success rates at every point and, as a result, reduce time-to-pregnancy, making IVF more affordable and accessible to patients globally. Life Whisperer is being used in IVF clinics around the world.

Presagen

Presagen is an AI healthcare company that is changing the way clinics, patients, and medical data from around the world are connected through AI. Its platform, The Social Network for Healthcare, connects clinics and patients globally, and enables collaboration and data sharing to create scalable AI healthcare products that are affordable and accessible for all. The decentralized network democratizes the creation of AI products, promotes collaboration through incentives, and protects data privacy and ownership. With a focus on improving Women’s Health outcomes globally, Presagen’s first product, Life Whisperer, is being used by IVF clinics globally to improve pregnancy outcomes for couples struggling with fertility. With a vision of creating the largest network of clinics, patients, and medical data from around the world, Presagen is driving the future of AI Enhanced Healthcare.

Share
82

Related posts

August 16, 2023

Can analysis of embryo appearance using artificial intelligence provide insight into the sex of your baby, and help prevent male bias in IVF?


Read more
August 8, 2023

Independent study shows Life Whisperer’s AI can predict the viability of embryos that have previously been frozen


Read more
July 20, 2023

Life Whisperer Genetics AI shows robust performance at varying times and stages of embryo development


Read more
March 6, 2023

ISAR Presentation: AI Enhanced Fertility


Read more

Comments are closed.

HIPAA and GDPR compliant and ISO 13485 certified.

CE Logo

Life Whisperer Viability and Genetics are commercially available in Australia, Canada, Europe (EEA), UK, Japan, India, UAE, Hong Kong, Israel, Malaysia, Thailand, Vietnam, Singapore, New Zealand, Turkey, Trinidad & Tobago, and Guyana (not available in the USA).

Life Whisperer Genetics is commercially available in the USA.

For sale to healthcare professionals only.

© Life Whisperer Diagnostics Pty Ltd     Terms and conditions   |   Privacy Policy   |   Fair Use Policy
  • Home
  • Products
  • Distribution
  • News & Science
  • About
  • Request a Trial